What is Quibim
Explore Quibim's AI-driven medical imaging solutions for oncology, neurology & metabolic disorders. FDA-cleared tools like QP-Prostate enhance diagnostics & pharmaceutical research through imaging biomarkers.
Overview of Quibim
- AI-Driven Medical Imaging Pioneer: Quibim develops foundational AI models that transform MRI, CT, and PET scans into actionable insights for precision medicine across oncology, neurology, and immunology.
- Global Clinical Implementation: With FDA/CE/UKCA-cleared solutions deployed in 170+ institutions worldwide including Stanford and Mass General Brigham, Quibim bridges research with clinical practice through quantitative imaging biomarkers.
- Strategic Industry Partnerships: Maintains collaborations with Philips for MR scanner integrations and biopharma leaders like Novartis/Merck KGaA for drug development companion diagnostics.
Use Cases for Quibim
- Oncology Workflow Optimization: Accelerates prostate cancer diagnosis through AI-assisted MRI interpretation while enabling treatment response prediction via tumor heterogeneity analysis.
- Clinical Trial Enhancement: Provides pharmaceutical partners with imaging biomarkers to stratify patients, monitor therapeutic efficacy in immunotherapy trials (Merck partnership), and reduce drug development timelines.
- Population Health Analytics: Powers Europe's Beating Cancer Plan through management of 10M+ de-identified oncology imaging datasets for predictive public health insights.
Key Features of Quibim
- QP-Prostate®: AI-powered prostate cancer detection software with 88% segmentation accuracy validated in international studies, featuring automated lesion detection and PSA density calculations.
- Whole-Body Analysis Suite: Combines QP-Brain® (neurological disease quantification), QP-Liver® (diffuse disease diagnosis), and upcoming whole-body digital twin capabilities for comprehensive tissue analysis.
- QP-Insights® Platform: Manages 100M+ medical images through hybrid cloud infrastructure with advanced data harmonization tools that standardize multi-vendor imaging equipment outputs.
Final Recommendation for Quibim
- Essential for Precision Oncology Programs: Hospitals implementing prostate MRI workflows should prioritize QP-Prostate® integration to improve diagnostic accuracy while reducing radiologist workload.
- Strategic Partner for Drug Developers: Biopharma companies engaged in immunotherapy/neurology trials benefit from Quibim's predictive biomarker panels to enhance patient selection criteria.
- Recommended Imaging Analytics Platform: Healthcare networks managing large-scale imaging repositories require QP-Insights® to unlock longitudinal analysis capabilities across multi-site datasets.
Frequently Asked Questions about Quibim
What is Quibim and what does it do?▾
Quibim is a medical imaging analytics platform that extracts quantitative image biomarkers and provides tools for visualization, analysis and reporting to support research, clinical workflows and drug development.
Which imaging modalities and file formats are supported?▾
Platforms like this typically support common modalities such as MRI, CT and PET and standard clinical formats like DICOM; check product documentation for any additional supported formats.
How do I upload images to the platform?▾
Images are usually uploaded via a secure web portal, direct DICOM transfer/PACS integration, or programmatically through APIs depending on your deployment and workflow needs.
How is patient data protected and is the platform compliant with regulations?▾
These solutions generally use encryption in transit and at rest, role-based access controls, and audit logging; they can be configured to support regulatory frameworks such as HIPAA and GDPR, but you should confirm specific compliance and contractual safeguards with the vendor.
Can Quibim integrate with PACS, RIS or electronic health records (EHR/EMR)?▾
Yes, integration is commonly offered via standard healthcare interfaces (DICOM, HL7, FHIR) and APIs to enable automated data exchange with PACS, RIS and EHR systems, though specific connectors and workflows should be verified.
Is there an API or SDK for automating workflows and integrations?▾
Most imaging analytics platforms provide REST APIs and/or SDKs to automate uploads, run analyses, and retrieve results; consult the developer documentation for available endpoints, authentication methods and code samples.
Who are the typical users of the platform?▾
Typical users include radiologists, imaging scientists, clinical researchers, pharmaceutical and biotech teams, and clinical trial organizations seeking quantitative imaging biomarkers and standardized analysis workflows.
Can I use the platform for clinical trials or regulatory submissions?▾
Quantitative imaging platforms are often used in clinical research and trials, but whether results are acceptable for regulatory submissions depends on validation, standardization of endpoints and the regulatory requirements for your indication—confirm with your regulatory team and the vendor.
How is pricing and licensing structured?▾
Pricing usually depends on factors such as deployment (cloud vs on-premises), analysis volume, number of users and needed integrations; vendors commonly offer subscription, per-study or enterprise licensing models and will provide quotes on request.
What support, training and professional services are available?▾
Vendors typically provide product documentation, onboarding assistance, user training, technical support and optional professional services for custom integrations, validation and study-specific workflows—ask the vendor for available packages and SLAs.
User Reviews and Comments about Quibim
Loading comments…
